Literature DB >> 30138057

Modeling Health Benefits and Harms of Public Policy Responses to the US Opioid Epidemic.

Allison L Pitt1, Keith Humphreys1, Margaret L Brandeau1.   

Abstract

OBJECTIVES: To estimate health outcomes of policies to mitigate the opioid epidemic.
METHODS: We used dynamic compartmental modeling of US adults, in various pain, opioid use, and opioid addiction health states, to project addiction-related deaths, life years, and quality-adjusted life years from 2016 to 2025 for 11 policy responses to the opioid epidemic.
RESULTS: Over 5 years, increasing naloxone availability, promoting needle exchange, expanding medication-assisted addiction treatment, and increasing psychosocial treatment increased life years and quality-adjusted life years and reduced deaths. Other policies reduced opioid prescription supply and related deaths but led some addicted prescription users to switch to heroin use, which increased heroin-related deaths. Over a longer horizon, some such policies may avert enough new addiction to outweigh the harms. No single policy is likely to substantially reduce deaths over 5 to 10 years.
CONCLUSIONS: Policies focused on services for addicted people improve population health without harming any groups. Policies that reduce the prescription opioid supply may increase heroin use and reduce quality of life in the short term, but in the long term could generate positive health benefits. A portfolio of interventions will be needed for eventual mitigation.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30138057      PMCID: PMC6137764          DOI: 10.2105/AJPH.2018.304590

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  34 in total

1.  Scientific evidence alone is not sufficient basis for health policy.

Authors:  Keith Humphreys; Peter Piot
Journal:  BMJ       Date:  2012-02-27

2.  Moving beyond misuse and diversion: the urgent need to consider the role of iatrogenic addiction in the current opioid epidemic.

Authors:  Gillian A Beauchamp; Erin L Winstanley; Shawn A Ryan; Michael S Lyons
Journal:  Am J Public Health       Date:  2014-09-11       Impact factor: 9.308

3.  Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal.

Authors:  Phillip O Coffin; Sean D Sullivan
Journal:  Ann Intern Med       Date:  2013-01-01       Impact factor: 25.391

4.  Time-to-Cessation of Postoperative Opioids: A Population-Level Analysis of the Veterans Affairs Health Care System.

Authors:  Seshadri C Mudumbai; Elizabeth M Oliva; Eleanor T Lewis; Jodie Trafton; Daniel Posner; Edward R Mariano; Randall S Stafford; Todd Wagner; J David Clark
Journal:  Pain Med       Date:  2016-04-15       Impact factor: 3.750

5.  The quality of eight health status measures were compared for chronic opioid dependence.

Authors:  Bohdan Nosyk; Huiyung Sun; Daphne P Guh; Eugenia Oviedo-Joekes; David C Marsh; Suzanne Brissette; Martin T Schechter; Aslam H Anis
Journal:  J Clin Epidemiol       Date:  2010-03-17       Impact factor: 6.437

6.  Weighing the Risks and Benefits of Chronic Opioid Therapy.

Authors:  Anna Lembke; Keith Humphreys; Jordan Newmark
Journal:  Am Fam Physician       Date:  2016-06-15       Impact factor: 3.292

Review 7.  Opioid epidemic in the United States.

Authors:  Laxmaiah Manchikanti; Standiford Helm; Bert Fellows; Jeffrey W Janata; Vidyasagar Pampati; Jay S Grider; Mark V Boswell
Journal:  Pain Physician       Date:  2012-07       Impact factor: 4.965

Review 8.  What are we treating with chronic opioid therapy?

Authors:  Daniel Krashin; Mark Sullivan; Jane Ballantyne
Journal:  Curr Rheumatol Rep       Date:  2013-03       Impact factor: 4.592

9.  Common chronic pain conditions in developed and developing countries: gender and age differences and comorbidity with depression-anxiety disorders.

Authors:  Adley Tsang; Michael Von Korff; Sing Lee; Jordi Alonso; Elie Karam; Matthias C Angermeyer; Guilherme Luiz Guimaraes Borges; Evelyn J Bromet; K Demytteneare; Giovanni de Girolamo; Ron de Graaf; Oye Gureje; Jean-Pierre Lepine; Josep Maria Haro; Daphna Levinson; Mark A Oakley Browne; Jose Posada-Villa; Soraya Seedat; Makoto Watanabe
Journal:  J Pain       Date:  2008-07-07       Impact factor: 5.820

10.  The severity of chronic pediatric pain: an epidemiological study.

Authors:  Anna Huguet; Jordi Miró
Journal:  J Pain       Date:  2007-12-21       Impact factor: 5.820

View more
  60 in total

1.  Clinical predictors of adverse cardiovascular events for acute pediatric drug exposures.

Authors:  Stephanie Carreiro; Simone Miller; Bo Wang; Paul Wax; Sharan Campleman; Alex F Manini
Journal:  Clin Toxicol (Phila)       Date:  2019-07-03       Impact factor: 4.467

2.  Modelling the combined impact of interventions in averting deaths during a synthetic-opioid overdose epidemic.

Authors:  Michael A Irvine; Margot Kuo; Jane A Buxton; Robert Balshaw; Michael Otterstatter; Laura Macdougall; M-J Milloy; Aamir Bharmal; Bonnie Henry; Mark Tyndall; Daniel Coombs; Mark Gilbert
Journal:  Addiction       Date:  2019-06-28       Impact factor: 6.526

3.  Prescription Drug Monitoring Program Mandates: Impact On Opioid Prescribing And Related Hospital Use.

Authors:  Hefei Wen; Jason M Hockenberry; Philip J Jeng; Yuhua Bao
Journal:  Health Aff (Millwood)       Date:  2019-09       Impact factor: 6.301

4.  Association between state Medicaid expansion status and naloxone prescription dispensing.

Authors:  Minji Sohn; Jeffery C Talbert; Chris Delcher; Emily R Hankosky; Michelle R Lofwall; Patricia R Freeman
Journal:  Health Serv Res       Date:  2020-02-07       Impact factor: 3.402

Review 5.  The Association of State Opioid Misuse Prevention Policies With Patient- and Provider-Related Outcomes: A Scoping Review.

Authors:  Amanda I Mauri; Tarlise N Townsend; Rebecca L Haffajee
Journal:  Milbank Q       Date:  2019-12-04       Impact factor: 4.911

6.  Overdose Risk and Acquiring Opioids for Nonmedical Use Exclusively from Physicians in Vancouver, Canada.

Authors:  Tessa Cheng; Will Small; Ekaterina Nosova; Robert Hogg; Kanna Hayashi; Thomas Kerr; Kora DeBeck
Journal:  Subst Use Misuse       Date:  2020-06-26       Impact factor: 2.164

7.  Laws Mandating Coprescription of Naloxone and Their Impact on Naloxone Prescription in Five US States, 2014-2018.

Authors:  Traci C Green; Corey Davis; Ziming Xuan; Alexander Y Walley; Jeffrey Bratberg
Journal:  Am J Public Health       Date:  2020-04-16       Impact factor: 9.308

8.  Findings from the recovery initiation and management after overdose (RIMO) pilot study experiment.

Authors:  Christy K Scott; Michael L Dennis; Christine E Grella; Lisa Nicholson; Jamie Sumpter; Rachel Kurz; Rod Funk
Journal:  J Subst Abuse Treat       Date:  2019-08-07

9.  Situating the Continuum of Overdose Risk in the Social Determinants of Health: A New Conceptual Framework.

Authors:  Ju Nyeong Park; Saba Rouhani; Leo Beletsky; Louise Vincent; Brendan Saloner; Susan G Sherman
Journal:  Milbank Q       Date:  2020-08-18       Impact factor: 4.911

10.  Opioid Prescribing Patterns Before Fatal Opioid Overdose.

Authors:  Ali B Abbasi; Elizabeth Salisbury-Afshar; Craig E Berberet; Jennifer E Layden; Mai T Pho
Journal:  Am J Prev Med       Date:  2020-02       Impact factor: 5.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.